Company Profile for Clovis Oncology

--(BUSINESS WIRE)--Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops diagnostic tools that direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado, and has additional offices in San Francisco, California and Cambridge, UK.

Company:	Clovis Oncology
Headquarters Address:	2525 28th Street, Suite 100
	Boulder, CO 80301
Main Telephone:	303-625-5000
Website:	www.clovisoncology.com
Ticker/ISIN:	CLVS(NASDAQ)/US1894641000
Type of Organization:	Public
Industry:	Biotechnology
Key Executives:	CEO: Patrick Mahaffy
	CFO: Erle Mast
Investor Relations
Contact:	Anna Sussman
Phone:	303-625-5022
Email:	[e-mail]
Investor Relations
Contact:	Breanna Burkart
Phone:	303-625-5023
Email:	[e-mail]